Health
Researchers unveil new SARS-CoV-2 inhibitor that targets viral immune evasion – News-Medical.Net
In a recent quest for an effective antiviral compound, UK researchers have purified a specific enzyme of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…
In a recent quest for an effective antiviral compound, UK researchers have purified a specific enzyme of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) known as nsp15 and optimized fluorescent biochemical endoribonuclease assays to screen a custom chemical library with over 5,000 commercial compounds. The study is currently available on the bioRxiv* preprint server.
SARS-CoV-2 is a causative agent of coronavirus disease 2019 (COVID-19), a human disease that resulted in millions…
-
Noosa News20 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News21 hours agoYoung voices shape Sunshine Coast’s future
-
Business20 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News18 hours agoStar Entertainment signs $300m lifeline deal with US gaming giant Bally’s